CorMedix Therapeutics (Nasdaq: CRMD) today provided a business update in advance of a conference call expected to be held on ...

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who ...

OncoC4, Inc., a late clinical-stage biopharmaceutical company developing novel medicines for cancer and immunological ...

Presentations to Explore Paxalisib's Differentiated Tumor and Immune Reprogramming Activity. SYDNEY, Nov. 2, 2026 /CNW/ -- ...

Protego Biopharma, Inc., a clinical-stage biotechnology company developing small-molecule therapies for protein misfolding ...

Karyopharm Therapeutics Inc. (Nasdaq: KPTI) ("Karyopharm" or the "Company"), a commercial-stage pharmaceutical company ...

Allowed claims cover Lowe syndrome and Dent disease 2; Can-Fite holds development, commercialization, and out-licensing ...

Early clinical data and additional preclinical data of HB2198 will be presented at the American College of Rheumatology (ACR) ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial-stage ...

The live webcast will be accessible via the “Investors & Media” section of the Climb Bio website. A webcast replay will be ...

(Nasdaq: CBLL) (“Ceribell” or the “Company”), a medical technology company focused on transforming the diagnosis and ...

Strong balance sheet, ending the quarter with $1.2 billion in cash and investments. Board authorizes share repurchase program ...